Elucidate Outcomes of Elective High-grade/Total Occlusion Intracranial Arteries Using Low-profile Self-expanding Stent
Launched by CAN THO STROKE INTERNATIONAL SERVICES HOSPITAL · Jul 9, 2023
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
In symptomatic ischemic stroke due to intracranial large severe stenosis or occlusive artery, the choice for treatment has remained controversial after results of the Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis (SAMMPRIS) trial because it demonstrated that the efficacy of medical treatment was superior to intracranial stenting (IS) in the low risk of periprocedural stroke or death. However, this conclusion has influenced the role of IS in the secondary prevention of ischemic stroke and recovery time for a long time because of the improper patient selection ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Evidence of severe intracranial stenosis
- • Target intracranial artery ≥ 2 mm
- • Absence of intracranial hemorrhage
- • Procedure treated with the Credo stent (Acandis, Pforzheim, Germany)
- Exclusion Criteria:
- • Premorbid modified Rankin Scale (mRS) score ≥ 2
- • Intracranial rescue stenting for acute ischemic stroke within 24 hours
- • Loss to follow-up after discharge
- • Systemic lupus erythematosus
- • More procedures at the same time
About Can Tho Stroke International Services Hospital
Can Tho Stroke International Services Hospital is a leading healthcare institution dedicated to advancing the field of stroke treatment and rehabilitation. Located in Can Tho, Vietnam, the hospital specializes in providing comprehensive care for stroke patients, leveraging cutting-edge technology and innovative medical practices. As a clinical trial sponsor, the hospital is committed to enhancing patient outcomes through rigorous research and the development of new therapeutic strategies. With a multidisciplinary team of experts, Can Tho Stroke International Services Hospital aims to contribute significantly to the global understanding of stroke management and to improve the quality of life for affected individuals.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cần Thơ, , Vietnam
Patients applied
Trial Officials
Cuong C Tran, PhD
Principal Investigator
Can Tho Stroke International Services General Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported